
Testimonials
Collated independently by Legal 500 research team.
‘Their industry-specific expertise focuses on sectors like biopharmaceuticals, AI, and semiconductors, leveraging gene-level equity structure design and pre-audit data compliance to ensure solutions are precisely tailored to business scenarios.’
'The Chenchen Gan team has redefined the logic of high-end legal services through the "Dual-Track Integration of Investment & Financing + Dispute Resolution," deeply incorporating their experience in private placement clause design into litigation strategies. They have established a predictive risk control system for high-risk areas such as S fund exits and control battles. Their industry-specific expertise focuses on sectors like biopharmaceuticals, AI, and semiconductors, leveraging gene-level equity structure design and pre-audit data compliance to ensure solutions are precisely tailored to business scenarios.'
Key clients
- China Resources National Corporation
- Qingdao Port International Co.,Ltd.
- Genor Biopharma Holdings Limited
- Edding Group Company Limited
- China Ruyi Holdings Limited
- Beijing Century Hong Shui Hospital Management Ltd.
- Hunan Silver Co., Ltd
- Dalian Bio-chem Company.,Limited.
- Foshan New Pearl Group Co., Ltd.
- Henan Shuanghui Investment & Development Co., Ltd.
- China Resources National Corporation
- Qingdao Port International Co.,Ltd.
Work highlights
Lawyers
Leading partners
The strongest partners in their field, leading on market-leading deals and endorsed by peers and clients alike.

Other key lawyers
Xiaoman Zhang; Chengchen Gan; Gang Wu; Haitao Jiang; Yuanmeng Ma; Jinqing Xiao
